Blood cancers

Treatment stage makes no difference to outcome for CLL patients with Covid

Patients with chronic lymphocytic leukaemia (CLL) who are hospitalised with Covid-19 have a high risk of mortality whether they are being treated for their cancer or not, a large international study has reported. Analysis of data from 198 CLL patients with Covid-19 across 43 centres found that 90% were admitted to hospital and after a ...

Already a member?

Login to keep reading.

© 2020 the limbic